| Income Statement |
| Total Revenue | 26.72M |
|
| Revenues (USD) | 26.72M |
| Cost of Revenue | 166.09M |
| Gross Profit | -139.37M |
| Operating Expenses | 11.45M |
| Research and Development Expense | 783.00K |
| Selling, General and Administrative Expense | 12.16M |
| Operating Income | -150.81M |
| Income Tax Expense | -21.64M |
| Net Income | -88.37M |
| Net Income Common Stock | -88.37M |
| Net Income Common Stock (USD) | -88.37M |
| Consolidated Income | -121.67M |
| Net Income to Non-Controlling Interests | -33.29M |
| Earning Before Interest & Taxes (EBIT) | -110.02M |
| Earning Before Interest & Taxes (USD) | -110.02M |
| Weighted Average Shares | 338.33M |
| Balance Sheet |
| Cash and Equivalents | 559.42M |
| Cash and Equivalents (USD) | 559.42M |
| Investments | 1.42B |
| Investments Current | 1.36B |
| Investments Non-Current | 64.59M |
| Trade and Non-Trade Receivables | 20.78M |
| Current Assets | 2.56B |
| Property, Plant & Equipment Net | 3.40B |
| Total Assets | 6.34B |
| Current Liabilities | 425.74M |
| Total Liabilities | 449.58M |
| Shareholders Equity | 4.39B |
| Shareholders Equity (USD) | 4.39B |
| Assets Non-Current | 3.78B |
| Deferred Revenue | 23.54M |
| Deposit Liabilities | 5.51M |
| Inventory | 258.28M |
| Liabilities Non-Current | 23.84M |
| Trade and Non-Trade Payables | 370.11M |
| Cash Flow |
| Net Cash Flow from Financing | -7.79M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -420.87M |
| Capital Expenditure | -28.69M |
| Net Cash Flow from Investing | -275.77M |
| Net Cash Flow - Investment Acquisitions and Disposals | -247.08M |
| Net Cash Flow from Operations | -147.51M |
| Effect of Exchange Rate Changes on Cash | 10.20M |